Eyestem is a cell therapy enterprise established by a distinguished management team comprising experts in clinical trials, cell therapy, and ophthalmology. Our platform integrates manufacturing and quality processes, fostering a continuous cycle of innovation and reducing time to market for these therapies. Our flagship product, Eyecyte-RPETM, developed from this platform, targets the treatment of Dry AMD (Age-related Macular ...
Eyestem is a cell therapy enterprise established by a distinguished management team comprising experts in clinical trials, cell therapy, and ophthalmology. Our platform integrates manufacturing and quality processes, fostering a continuous cycle of innovation and reducing time to market for these therapies. Our flagship product, Eyecyte-RPETM, developed from this platform, targets the treatment of Dry AMD (Age-related Macular Degeneration). Dry AMD stands as the leading cause of irreversible blindness in individuals over 60, impacting approximately 170 million people globally.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.